Bausch Health
BHC
#4839
Rank
NZ$3.70 B
Marketcap
NZ$9.90
Share price
0.36%
Change (1 day)
-17.44%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): NZ-$5.67

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is NZ-$5.64. In 2025 the company made an earnings per share (EPS) of NZ$0.73 an increase over its 2024 EPS that were of NZ-$0.21.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.67-876.14%
2025NZ$0.73-450%
2024NZ-$0.21-92.59%
2023NZ-$2.82160.89%
2022NZ-$1.08-76.64%
2021NZ-$4.6268.45%
2020NZ-$2.74-68.91%
2019NZ-$8.83-57.11%
2018NZ-$20.58-272.22%
2017NZ$11.95-199.29%
2016NZ-$12.04798.7%
2015NZ-$1.34-128.31%
2014NZ$4.73-204.62%
2013NZ-$4.52602.7%
2012NZ-$0.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.47-91.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.65-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA